Priority for pSivida's Iluvien; Patent, job, Tweet, and Video of the week;

>  The FDA has granted priority review status for Iluvien, a sustained drug delivery system to treat diabetic macular edema. Iluvien was designed by Watertown, MA-based pSivida and licensed to Alimera Sciences based in Alpharetta, GA. Report

>  The Institute of Nanotechnology and Cranfield University in the United Kingdom will present a one-day short course, "Nanotechnology for drug delivery," in association with Pharmidex, on Sept. 30. Event

>  Using carbon nanotubes to delivery siRNA. Abstract

>  Coming attractions from the FDA: New guidance and consensus standards on nanotechnology as part of its 2011 Nanotechnology Regulatory Science Initiative. Bulletin

>  A transdermal patch for delivery of contraceptives is among the offerings in India's first patent tech auction. Report

Drug delivery patent of the week: Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization. Patent

Drug delivery job of the week: Dry Powder Inhaler Formulator--3M Drug Delivery Systems Division, Maplewood, MN. Listing

Drug delivery Tweet of the week: @juhayy I think I died a little inside after a short lecture on intraocular way of drug delivery. Five ways of sticking a needle in the eyeball: oh my. Tweet

And Finally... CNN discovers the flu patch. Video

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.